Species | Target name | Source | Bibliographic reference |
---|---|---|---|
Homo sapiens | ataxin 2 | Starlite/ChEMBL | No references |
Homo sapiens | geminin, DNA replication inhibitor | Starlite/ChEMBL | No references |
Species | Potential target | Known druggable target | Length | Alignment span | Identity |
---|---|---|---|---|---|
Brugia malayi | Hypothetical 65.5 kDa Trp-Asp repeats containing protein F02E8.5 inchromosome X | geminin, DNA replication inhibitor | 209 aa | 176 aa | 27.8 % |
Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Echinococcus multilocularis | tumor protein p63 | 0.066 | 1 | 1 |
Plasmodium falciparum | SWIB/MDM2 domain-containing protein | 0.0303 | 0.4426 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0108 | 0.1376 | 0.2837 |
Schistosoma mansoni | hypothetical protein | 0.0303 | 0.4426 | 1 |
Toxoplasma gondii | ran binding protein | 0.0108 | 0.1376 | 0.2837 |
Onchocerca volvulus | 0.0108 | 0.1376 | 0.0542 | |
Trypanosoma cruzi | hypothetical protein, conserved | 0.0108 | 0.1376 | 1 |
Echinococcus multilocularis | SWI:SNF matrix associated | 0.0303 | 0.4426 | 0.3536 |
Schistosoma mansoni | TRABID protein (C64 family) | 0.0108 | 0.1376 | 0.0542 |
Chlamydia trachomatis | DNA topoisomerase I | 0.0303 | 0.4426 | 0.5 |
Schistosoma mansoni | brg-1 associated factor | 0.0303 | 0.4426 | 1 |
Echinococcus multilocularis | SWI:SNF matrix associated | 0.0303 | 0.4426 | 0.3536 |
Plasmodium falciparum | SWIB/MDM2 domain-containing protein | 0.0303 | 0.4426 | 1 |
Schistosoma mansoni | zinc finger protein | 0.0108 | 0.1376 | 0.0542 |
Trypanosoma brucei | Zn-finger in Ran binding protein and others/FYVE zinc finger, putative | 0.0108 | 0.1376 | 1 |
Onchocerca volvulus | Ubiquitin thioesterase ZRANB1 homolog | 0.0108 | 0.1376 | 0.0542 |
Trypanosoma cruzi | hypothetical protein, conserved | 0.0108 | 0.1376 | 1 |
Leishmania major | hypothetical protein, conserved | 0.0108 | 0.1376 | 1 |
Brugia malayi | Zn-finger in Ran binding protein and others containing protein | 0.0108 | 0.1376 | 0.311 |
Loa Loa (eye worm) | hypothetical protein | 0.0108 | 0.1376 | 0.2837 |
Leishmania major | hypothetical protein, conserved | 0.0108 | 0.1376 | 1 |
Trypanosoma brucei | mitochondrial RNA binding complex 1 subunit | 0.0108 | 0.1376 | 1 |
Schistosoma mansoni | hypothetical protein | 0.0108 | 0.1376 | 0.0542 |
Schistosoma mansoni | hypothetical protein | 0.0303 | 0.4426 | 1 |
Schistosoma mansoni | hypothetical protein | 0.0205 | 0.2891 | 0.5239 |
Trypanosoma cruzi | WLM domain containing protein, putative | 0.0108 | 0.1376 | 1 |
Brugia malayi | Zn-finger in Ran binding protein and others containing protein | 0.0108 | 0.1376 | 0.311 |
Trypanosoma cruzi | hypothetical protein, conserved | 0.0108 | 0.1376 | 1 |
Brugia malayi | Zn-finger in Ran binding protein and others containing protein | 0.0108 | 0.1376 | 0.311 |
Trypanosoma cruzi | WLM domain containing protein, putative | 0.0108 | 0.1376 | 1 |
Onchocerca volvulus | 0.0108 | 0.1376 | 0.0542 | |
Loa Loa (eye worm) | hypothetical protein | 0.0108 | 0.1376 | 0.2837 |
Toxoplasma gondii | Zn-finger in Ran binding protein and others domain-containing protein | 0.0108 | 0.1376 | 0.2837 |
Chlamydia trachomatis | SWIB complex protein | 0.0303 | 0.4426 | 0.5 |
Loa Loa (eye worm) | SWIB/MDM2 domain-containing protein | 0.0303 | 0.4426 | 1 |
Echinococcus granulosus | SWI:SNF matrix associated | 0.0303 | 0.4426 | 0.3536 |
Loa Loa (eye worm) | brahma associated protein | 0.0303 | 0.4426 | 1 |
Onchocerca volvulus | 0.0303 | 0.4426 | 1 | |
Schistosoma mansoni | RNA binding protein | 0.0108 | 0.1376 | 0.0542 |
Echinococcus granulosus | Upstream activation factor subunit UAF30 | 0.0303 | 0.4426 | 0.3536 |
Leishmania major | hypothetical protein, conserved | 0.0108 | 0.1376 | 1 |
Trypanosoma brucei | hypothetical protein, conserved | 0.0108 | 0.1376 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0097 | 0.1202 | 0.2426 |
Toxoplasma gondii | SWIB/MDM2 domain-containing protein | 0.0303 | 0.4426 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0108 | 0.1376 | 0.2837 |
Brugia malayi | brahma associated protein 60 kDa | 0.0303 | 0.4426 | 1 |
Trypanosoma cruzi | Zn-finger in Ran binding protein and others, putative | 0.0108 | 0.1376 | 1 |
Echinococcus multilocularis | SWI:SNF matrix associated | 0.0303 | 0.4426 | 0.3536 |
Onchocerca volvulus | 0.0108 | 0.1376 | 0.0542 | |
Schistosoma mansoni | fusion | 0.0108 | 0.1376 | 0.0542 |
Loa Loa (eye worm) | hypothetical protein | 0.0108 | 0.1376 | 0.2837 |
Trypanosoma cruzi | Zn-finger in Ran binding protein and others/FYVE zinc finger, putative | 0.0108 | 0.1376 | 1 |
Plasmodium vivax | hypothetical protein, conserved | 0.0303 | 0.4426 | 1 |
Schistosoma mansoni | hypothetical protein | 0.0205 | 0.2891 | 0.5239 |
Leishmania major | hypothetical protein, conserved | 0.0108 | 0.1376 | 1 |
Brugia malayi | brahma associated protein 60 kDa | 0.0303 | 0.4426 | 1 |
Plasmodium falciparum | zinc finger Ran-binding domain-containing protein 2, putative | 0.0108 | 0.1376 | 0.2837 |
Brugia malayi | SWIB/MDM2 domain containing protein | 0.0303 | 0.4426 | 1 |
Schistosoma mansoni | hypothetical protein | 0.0303 | 0.4426 | 1 |
Brugia malayi | YY1-associated factor 2 | 0.0108 | 0.1376 | 0.311 |
Brugia malayi | hypothetical protein | 0.003 | 0.0169 | 0.0381 |
Leishmania major | hypothetical protein, conserved | 0.0108 | 0.1376 | 1 |
Trypanosoma cruzi | Zn-finger in Ran binding protein and others, putative | 0.0108 | 0.1376 | 1 |
Brugia malayi | Zn-finger in Ran binding protein and others containing protein | 0.0108 | 0.1376 | 0.311 |
Echinococcus multilocularis | Upstream activation factor subunit UAF30 | 0.0303 | 0.4426 | 0.3536 |
Plasmodium vivax | SWIB/MDM2 domain-containing protein, putative | 0.0303 | 0.4426 | 1 |
Echinococcus granulosus | geminin | 0.0205 | 0.2891 | 0.1756 |
Trypanosoma cruzi | mitochondrial RNA binding complex 1 subunit, putative | 0.0108 | 0.1376 | 1 |
Trypanosoma cruzi | mitochondrial RNA binding complex 1 subunit, putative | 0.0108 | 0.1376 | 1 |
Trypanosoma brucei | hypothetical protein, conserved | 0.0108 | 0.1376 | 1 |
Echinococcus multilocularis | geminin | 0.0205 | 0.2891 | 0.1756 |
Onchocerca volvulus | 0.0108 | 0.1376 | 0.0542 | |
Toxoplasma gondii | DNA topoisomerase domain-containing protein | 0.0303 | 0.4426 | 1 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0303 | 0.4426 | 0.5 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
Potency (functional) | 0.1 uM | PubChem BioAssay. qHTS for Inhibitors of ATXN expression. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | 2.9362 uM | PUBCHEM_BIOASSAY: Primary qHTS for delayed death inhibitors of the malarial parasite plastid, 96 hour incubation. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488745, AID488752, AID488774, AID504848, AID504850] | ChEMBL. | No reference |
Potency (functional) | 11.5821 uM | PubChem BioAssay. A quantitative high throughput screen for small molecules that induce DNA re-replication in SW480 colon adenocarcinoma cells. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | 89.1251 uM | PUBCHEM_BIOASSAY: qHTS for Inhibitors of Polymerase Eta. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID588636] | ChEMBL. | No reference |
Potency (functional) | 100 uM | PubChem BioAssay. qHTS for Antagonist of cAMP-regulated guanine nucleotide exchange factor 3 (EPAC1): primary screen. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | 112.2018 uM | PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of Rango (Ran-regulated importin-beta cargo) - Importin beta complex formation. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID540273] | ChEMBL. | No reference |
Species name | Source | Reference | Is orphan |
---|---|---|---|
Plasmodium falciparum | ChEMBL23 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.